Skip to content
mapperlab
← Dashboard
Stock

STE

STERIS plc
Health CareHealth Care Equipment7 of 27 marquee funds currently hold3 CUSIPs mapped
Current holders
7
27 funds tracked
Ever held
10
Current + past
New this quarter
0
Exited this quarter
1

Marquee-fund ownership over time

Nov 12, 2015Feb 13, 2019Nov 14, 2024May 14, 2026
Now
7

This quarter's activity

New positions opened

None.

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates re-entered$0.00——
Citadel Advisors$0.00——
Two Sigma Investments$0.00——
D.E. Shaw re-entered$0.00——
AQR Capital Management$0.00——
Millennium Management$0.00——
Point72 Asset Management re-entered$0.00——

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Renaissance Technologies—+0%
Maverick Capital—+0%
Elliott Management—+0%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at STERIS plc. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
34
Filings · last 90d
34
Total on file
404
Recent SEC buffer
Most recent
Jun 8, 2026

30d / 90d windows measured from Jun 8, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 404 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · STERIS plc

Annual figures sourced directly from STERIS plc's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$5.94B
FY2026+9% YoY
Net income
$782.3M
FY2026+27% YoY
EPS (diluted)
$7.93
FY2026+28% YoY
Free cash flow(?)
$972.4M
FY2026+25% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for STERIS plc — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Point72 Asset ManagementQ1 2026open$0.00—+0%
Renaissance TechnologiesQ3 2025Q2 2026$0.00—+0%
Point72 Asset ManagementQ2 2025Q4 2025$0.00—+0%
D.E. ShawQ1 2025open$0.00—+0%
Citadel AdvisorsQ3 2024open$0.00—+0%
Two Sigma InvestmentsQ3 2024open$0.00—+0%
D.E. ShawQ3 2024Q4 2024$0.00—+0%
AQR Capital ManagementQ3 2024open$0.00—+0%
Millennium ManagementQ3 2024open$0.00—+0%
Maverick CapitalQ1 2021Q2 2021$0.00—+0%
Bridgewater AssociatesQ4 2020open$0.00—+0%
Bridgewater AssociatesQ1 2019Q2 2019$0.00—+0%
Bridgewater AssociatesQ2 2018Q4 2018$0.00—+0%
Elliott ManagementQ1 2016Q2 2016$0.00—+0%
Bridgewater AssociatesQ4 2015Q1 2016$0.00—+0%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.